Improving Diabetes Care in Practice: findings from the TRANSLATE trial

Kevin A Peterson, David M Radosevich, Patrick J O'Connor, John A Nyman, Ronald J Prineas, Steven A Smith, Thomas J Arneson, Victor A Corbett, Joyce C Weinhandl, Carol J Lange, Peter J Hannan, Kevin A Peterson, David M Radosevich, Patrick J O'Connor, John A Nyman, Ronald J Prineas, Steven A Smith, Thomas J Arneson, Victor A Corbett, Joyce C Weinhandl, Carol J Lange, Peter J Hannan

Abstract

Objective: The purpose of this study was to determine whether implementation of a multicomponent organizational intervention can produce significant change in diabetes care and outcomes in community primary care practices.

Research design and methods: This was a group-randomized, controlled clinical trial evaluating the practical effectiveness of a multicomponent intervention (TRANSLATE) in 24 practices. The intervention included implementation of an electronic diabetes registry, visit reminders, and patient-specific physician alerts. A site coordinator facilitated previsit planning and a monthly review of performance with a local physician champion. The principle outcomes were the percentage of patients achieving target values for the composite of systolic blood pressure (SBP) <130 mmHg, LDL cholesterol <100 mg/dl, and A1C <7.0% at baseline and 12 months. Six process measures were also followed.

Results: Over 24 months, 69,965 visits from 8,405 adult patients with type 2 diabetes were recorded from 238 health care providers in 24 practices from 17 health systems. Diabetes process measures increased significantly more in intervention than in control practices, giving net increases as follows: foot examinations 35.0% (P < 0.0.001); annual eye examinations 25.9% (P < 0.001); renal testing 28.5% (P < 0.001); A1C testing 8.1%(P < 0.001); blood pressure monitoring 3.5% (P = 0.05); and LDL testing 8.6% (P < 0.001). Mean A1C adjusted for age, sex, and comorbidity decreased significantly in intervention practices (P < 0.02). At 12 months, intervention practices had significantly greater improvement in achieving recommended clinical values for SBP, A1C, and LDL than control clinics (P = 0.002).

Conclusions: Introduction of a multicomponent organizational intervention in the primary care setting significantly increases the percentage of type 2 diabetic patients achieving recommended clinical outcomes.

Trial registration: ClinicalTrials.gov NCT00108927.

References

    1. Association American Diabetes: Standards of medical care in diabetes—2008. Diabetes Care 31:S12–S54, 2008
    1. Saddine J, Engelgau M, Beckles G, Gregg E, Thompson T, Narayan K: A diabetes report card for the United States: quality of care in the 1990's. Ann Intern Med 136:565–574, 2002
    1. Testa MA, Simonson DC: Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus. JAMA 280:1490–1496, 1998
    1. UKPDS Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703–713, 1998
    1. Shojania KG, Ranji SR, McDonald KM: Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA 296:427–440, 2006
    1. Institute of Medicine. Primary Care: America's Health in a New Era. Washington, DC, National Academies Press, 1996
    1. Casalino LP: Disease management and the organization of physician practice. JAMA 293:485–488, 2005
    1. Oxman AD, Thomson MA, Davis DA, Gaynes RB: No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ 153:1423–1431, 1995
    1. Peterson KA, Vinicor F: Strategies to improve diabetes care delivery. J Fam Pract 47:55–62, 1998
    1. Casalino L, Gillies RR, Shortell SM, Schmittdiel JA, Bodenheimer T, Robinson JC, Rundall T, Oswald N, Schauffler H, Wang MC: External incentives, information technology, and organized processes to improve health care quality for patients with chronic diseases. JAMA 289:434–441, 2003
    1. McCulloch DK, Price MJ, Hindmarsh M, Wagner EH: A population-based approach to diabetes management in a primary care setting: early results and lessons learned. Eff Clin Pract 1:12–22, 1998
    1. Meigs JB, Cagliero E, Dubey A, Murphy-Sheehy P, Gildesgame C, Chueh H, Barry MJ, Singer DE, Nathan DM: A controlled trial of web-based diabetes disease management: the MGH diabetes primary care improvement project. Diabetes Care 26:750–757, 2003
    1. Stroebel RJ, Scheitel SM, Fitz JS, Herman RA, Naessens JM, Scott CG, Zill DA, Muller L: A randomized trial of three diabetes registry implementation strategies in a community internal medicine practice. Jt Comm J Qual Improv 28:441–450, 2002
    1. Wang A, Wolf M, Carlyle R, Wilkerson J, Porterfield D, Reaves J: The North Carolina experience with the diabetes health disparities collaboratives. Jt Comm J Qual Saf 30:396–404, 2004
    1. O'Connor PJ, Desai J, Solberg LI, Reber LA, Crain AL, Asche SE, Pearson TL, Clark CK, Rush WA, Cherney LM, Sperl-Hillen JM, Bishop DB: Randomized trial of quality improvement intervention to improve diabetes care in primary care settings. Diabetes Care 28:1890–1897, 2005
    1. Glasgow RE, Nutting PA, King DK, Nelson CC, Cutter G, Gaglio B, Rahm AK, Whitesides H, Amthauer H: A practical randomized trial to improve diabetes care. J Gen Intern Med 19:1167–1174, 2004
    1. Mangione CM, Gerzoff RB, Williamson DF, Steers WN, Kerr EA, Brown AF, Waitzfelder BE, Marrero DG, Dudley RA, Kim C, Herman W, Thompson TJ, Safford MM, Selby JV: The association between quality of care and the intensity of diabetes disease management programs. Ann Intern Med 145:107–116, 2006
    1. Ackermann RT, Thompson TJ, Selby JV, Safford MM, Stevens M, Brown AF, Venkat Narayan KM: Is the number of documented diabetes process-of-care indicators associated with cardiometabolic risk factor levels, patient satisfaction, or self-rated quality of diabetes care? The Translating Research into Action for Diabetes (TRIAD) study. Diabetes Care 29:2108–2113, 2006
    1. Tunis SR, Stryer DB, Clancy CM: Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 290:1624–1632, 2003
    1. Donner A, Klar N: Design and Analysis of Cluster Randomization in Health Research. London, Arnold Publishers, 2000
    1. Murray DM. Design and Analysis of Group-Randomized Trials. Vol. 27. New York, Oxford University Press, 1998
    1. Wagner EH: Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract 1:2–4, 1998
    1. American Medical Association, Joint Commission on Accreditation of Healthcare Organizations, National Committee for Quality Assurance: Consensus statement: Coordinated Performance Measurement for the Management of Adult Diabetes, 2001
    1. Brown H, Prescott R: Applied Mixed Models in Medicine. Chichester, UK, John Wiley & Sons, 1999
    1. Littell RC, Milliken GA, Stroup WW, Wolfinger RD: SAS System for Mixed Models. Cary, NC: SAS Institute, 1996
    1. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383, 1987
    1. D'Hoore W, Bouckaert A, Tilquin C: Practical considerations on the use of the Charlson comorbidity index with administrative data bases. J Clin Epidemiol 49:1429–1433, 1996
    1. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pederson O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383–393, 2003

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir